Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer

In the present study, we aimed to evaluate the association of circulating AR copy number (CN) and outcome in a cohort of patients with advanced castration-resistant prostate cancer (CRPC) treated with enzalutamide after docetaxel. Fifty-nine CRPC patients were evaluated. AR CN was analyzed with real...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Salvi, Samanta, Casadio, Valentina, Conteduca, Vincenza, Lolli, Cristian, Gurioli, Giorgia, Martignano, Filippo, Schepisi, Giuseppe, Testoni, Sara, Scarpi, Emanuela, Amadori, Dino, Calistri, Daniele, Attard, Gerhardt, Giorgi, Ugo De
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2016
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122353/
https://ncbi.nlm.nih.gov/pubmed/27191887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9341
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi